Your browser doesn't support javascript.
loading
Comparison of upper airway obstruction during zolpidem-induced sleep and propofol-induced sleep in patients with obstructive sleep apnea: a pilot study.
Ordones, Alexandre Beraldo; Grad, Gustavo Freitas; Cahali, Michel Burihan; Lorenzi-Filho, Geraldo; Sennes, Luiz Ubirajara; Genta, Pedro Rodrigues.
Afiliación
  • Ordones AB; Department of Otolaryngology, Universidade de São Paulo, São Paulo, Brazil.
  • Grad GF; Pulmonary Division, Heart Institute (InCor), Universidade de São Paulo, São Paulo, Brazil.
  • Cahali MB; Department of Otolaryngology, Universidade de São Paulo, São Paulo, Brazil.
  • Lorenzi-Filho G; Pulmonary Division, Heart Institute (InCor), Universidade de São Paulo, São Paulo, Brazil.
  • Sennes LU; Department of Otolaryngology, Universidade de São Paulo, São Paulo, Brazil.
  • Genta PR; Pulmonary Division, Heart Institute (InCor), Universidade de São Paulo, São Paulo, Brazil.
J Clin Sleep Med ; 16(5): 725-732, 2020 05 15.
Article en En | MEDLINE | ID: mdl-32029070
ABSTRACT
STUDY

OBJECTIVES:

Drug-induced sleep endoscopy (DISE) using propofol is commonly used to identify the pharyngeal structure involved in collapse among patients with obstructive sleep apnea. DISE has never been compared with zolpidem-induced sleep endoscopy. We hypothesized that propofol at recommended sedation levels does not influence upper airway collapsibility nor the frequency of multilevel pharyngeal collapse as compared with zolpidem-induced sleep.

METHODS:

Twenty-one patients with obstructive sleep apnea underwent polysomnography and sleep endoscopy during zolpidem-induced sleep and during DISE with propofol. A propofol target-controlled infusion was titrated to achieve a bispectral index between 50 and 70. Airway collapsibility was estimated and compared in both conditions by peak inspiratory flow and the magnitude of negative effort dependence. Respiratory drive was estimated by the difference between end-expiratory and peak-negative inspiratory pharyngeal pressure (driving pressure). Site and configuration of pharyngeal collapse during zolpidem-induced sleep and DISE with propofol were compared.

RESULTS:

The frequency of multilevel collapse during zolpidem-induced sleep was similar to that observed during DISE with propofol (72% vs 86%, respectively; difference 14%; 95% confidence interval -12% to 40%; P = .453). The endoscopic classification of pharyngeal collapse during both conditions were similar. Peak inspiratory flow, respiratory drive (effect size 0.05 and 0.03, respectively), and negative effort dependence (difference -6%; 95% confidence interval -16% to 4%) were also similar in both procedures.

CONCLUSIONS:

In this pilot study, recommended propofol doses did not significantly increase multilevel pharyngeal collapse or affect upper airway collapsibility and respiratory drive as compared with zolpidem-induced sleep. CLINICAL TRIAL REGISTRATION Registry clinicaltrials.gov; Name Natural and Drug Sleep Endoscopy; URL https//clinicaltrials.gov/ct2/show/study/NCT03004014; Identifier NCT03004014.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Propofol / Apnea Obstructiva del Sueño / Obstrucción de las Vías Aéreas Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Clin Sleep Med Año: 2020 Tipo del documento: Article País de afiliación: Brasil

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Propofol / Apnea Obstructiva del Sueño / Obstrucción de las Vías Aéreas Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Clin Sleep Med Año: 2020 Tipo del documento: Article País de afiliación: Brasil
...